目錄:MedChemExpress LLC>>生化試劑>> ORIC-101 | MCE
CAS | 2222344-98-9 | 純度 | 99.30% |
---|---|---|---|
分子量 | 501.74 | 分子式 | C??H??NO? |
供貨周期 | 現(xiàn)貨 | 貨號 | HY-112710 |
應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務(wù)。
CAS No. : 2222344-98-9
產(chǎn)品活性:ORIC-101 is a highly potent and selective glucocorticoid receptor antagonist, with an EC50 of 5.6 nM. Anti-cancer activity.
研究領(lǐng)域:Immunology/Inflammation | Vitamin D Related/Nuclear Receptor
作用靶點:Glucocorticoid Receptor
In Vitro: ORIC-101 shows markedly reduced androgen receptor agonism (EC50, 2500 nM) and CYP2C8 and CYP2C9 inhibition profiles (IC50, >10 μM).
ORIC-101 (1-1000 nM) dose-dependently reduces the expression of n GR-mediated target gene (FKBP5 and GILZ), with IC50s of 17.2 and 21.2 nM, respectively.
In Vivo: ORIC-101 (75 mg/kg, P.O. twice a day for 16-22 days) enhances the anti-tumor activity in combination with gemcitabine and carboplatin in OVCAR5 xenograft tumor in cortisol-treated mice.
相關(guān)產(chǎn)品:Clinical Compound Library Plus | Bioactive Compound Library Plus | Medroxyprogesterone acetate-d3 | Prednisolone acetate | Clobetasone butyrate | Mifepristone-13C,d3 | Deflazacort | C108297 | Nenocorilant | Methylprednisolone succinate | Medroxyprogesterone acetate | Betamethasone 21-phosphate-d5 | Betamethasone dipropionate-d10 | Fluticasone propionate-d5 | Methylprednisolone-d5 | Fluticasone furoate-d3 | Dexamethasone-d4 | Mizacorat | Beclometasone dipropionate | Mifepristone-d3 | Methylprednisolone-d2 | Beclometasone dipropionate-d10 | Prednisone-d8 | Prednisolone Tebutate | Hydrocortisone hemisuccinate | Betamethasone-d5-1 | OP-3633 | Glucocorticoid receptor agonist-1 | Triamcinolone Benetonide
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物 | 寡核苷酸 | 抗體 | 點擊化學(xué)
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領(lǐng);
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學(xué)分析檢測分析,藥物篩選等專業(yè)技術(shù)服務(wù);
• 設(shè)有專業(yè)的實驗中心和嚴(yán)格的質(zhì)控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質(zhì)檢報告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團(tuán)隊跟蹤最新的制藥及生命科學(xué)研究進(jìn)展,為您提供*新的活性化合物;
• 與世界各大制藥公司及著名科研機(jī)構(gòu)建立了長期的合作。
(空格分隔,最多3個,單個標(biāo)簽最多10個字符)